Schizophrenia Drug Linked to Pneumonia, Gut Disorders in 25-Year Follow-Up Study
By Huey Freeman Recent research has linked clozapine, a powerful medication for schizophrenia, to an increased risk of mortality associated with pneumonia and severe gastrointestinal complications. Clozapine is the only drug in the United States approved to treat “treatment-resistant schizophrenia,” which affects one in five schizophrenic patients. It was removed from global markets in…
More Stories
Snowflake’s (SNOW) “Buy” Rating Reaffirmed at Rosenblatt Securities
Snowflake (NYSE:SNOW – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Rosenblatt Securities in...
Snap-on’s (SNA) Outperform Rating Reiterated at Barrington Research
Snap-on (NYSE:SNA – Get Free Report)‘s stock had its “outperform” rating reiterated by equities research analysts at Barrington Research in...
Charter Communications (NASDAQ:CHTR) Upgraded by Loop Capital to Buy Rating
Charter Communications (NASDAQ:CHTR – Get Free Report) was upgraded by research analysts at Loop Capital from a “hold” rating to...
Y-mAbs Therapeutics (NASDAQ:YMAB) Price Target Lowered to $11.00 at HC Wainwright
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report) had its price objective lowered by HC Wainwright from $12.00 to $11.00 in...
UBS Group Upgrades Delta Air Lines (NYSE:DAL) to Buy
Delta Air Lines (NYSE:DAL – Get Free Report) was upgraded by analysts at UBS Group from a “neutral” rating to...
Patterson-UTI Energy’s (PTEN) Neutral Rating Reaffirmed at Citigroup
Patterson-UTI Energy (NASDAQ:PTEN – Get Free Report)‘s stock had its “neutral” rating reiterated by stock analysts at Citigroup in a...